Description
Product Overview: Xtandi is a potent medication indicated for the treatment of prostate cancer, particularly in patients with metastatic castration-resistant prostate cancer (mCRPC). Each capsule of Xtandi contains 40 mg of Enzalutamide, the active pharmaceutical ingredient known for its efficacy in inhibiting androgen receptor signaling. Manufactured to the highest standards by Astellas Pharma India Pvt. Ltd., Xtandi offers advanced therapy and hope for patients battling prostate cancer.
Key Features:
- Androgen Receptor Inhibitor: Xtandi contains Enzalutamide, a next-generation androgen receptor inhibitor that blocks androgen signaling at multiple points within the pathway, thereby suppressing cancer growth and progression.
- Targeted Therapy: By specifically targeting androgen receptor signaling, Xtandi provides a precision approach to treating prostate cancer, even in advanced stages where other treatments may have failed.
- Convenient Dosage Form: Each pack of Xtandi contains 112 capsules of 40 mg strength, providing patients with a convenient and reliable dosage regimen for long-term therapy.
- Manufactured by Astellas Pharma India Pvt. Ltd.: Xtandi is manufactured by Astellas Pharma India Pvt. Ltd., a leading pharmaceutical company dedicated to advancing medical science and improving patient outcomes.
Indications: Xtandi is indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men who have previously received docetaxel-based chemotherapy and in those who are chemotherapy-naïve.
Usage Instructions: Xtandi capsules should be taken orally as directed by a healthcare professional, typically once daily with or without food. The capsules should be swallowed whole and not opened, crushed, or chewed. It is important to follow the dosage regimen and any additional instructions provided by the prescribing physician.
Safety Information:
- Prior to initiating treatment with Xtandi, patients should undergo thorough evaluation, including assessment of medical history, current medications, and baseline laboratory tests.
- Adverse reactions such as fatigue, hypertension, hot flushes, and musculoskeletal events may occur during treatment with Xtandi. Patients should be monitored regularly for any signs of adverse effects and managed accordingly.
- Xtandi may interact with certain medications, so it is essential to inform the healthcare provider about all medications being taken, including prescription, over-the-counter, and herbal supplements.
- Use of Xtandi in women, particularly pregnant or breastfeeding women, should be avoided, as it may cause harm to the fetus or nursing infant.
Storage: Xtandi should be stored as per the manufacturer’s instructions, typically at controlled room temperature away from light and moisture. Unused portions should be kept in the original packaging and out of reach of children.
Disclaimer: The information provided here is for educational purposes only and does not substitute medical advice. Patients should consult their healthcare provider for personalized recommendations and treatment options.
Reviews
There are no reviews yet.